Newsletter  |  April 2015  
REDEFINING QUALITY - Full Service Provider Focused on Early Stage Clinical Research

Did You Miss our Latest News?

We now have the ability to play a key role in the evolution of CDISC standards. As a CDISC Gold member Algorithme Phama can further collaborate with global leaders and contribute toward the development and release of new standards.

Read the Press Release  >>

Cardiac Safety Symposium

An Emerging Alternative to Thorough QT Studies Using Early Phase QT Assessment

On Wednesday, April 15, from 9 a.m. to 1 p.m. in Boston, industry experts Borje Darpo (MD, PhD), Eva Bredberg (PhD), and Lorraine Rusch (PhD), will present at the Cardiac Safety Symposium, hosted by the Clinical Pharmacology Discussion Group. Drug induced proarrhythmia is a major consideration during pharmaceutical drug development. These experts will examine a new methodology created through a collaboration between the IQ Consortium and the Cardiac Safety Research Consortium for early QT assessment with the potential to get TQT-like statistical power in Phase I/II trials.

For details and to register  >> logo

WRIB — Join Us for the Presentation of Five Posters

We look forward to seeing you at the 9th Workshop on Recent Issues in Bioanalysis (WRIB), from April 13th to 17th in Miami, Florida. Meet us at booth #49 and be sure to attend our poster presentations:


Application and Advantages of HRMS in the Quantification of Therapeutic Monoclonal Antibodies: "The Rituximab Case Study"



Request a meeting  >>

Endothelin-1: Validation of a High Sensitivity Quantitative Human Plasma Chemiluminescence Immunoassay



Request a meeting  >>

Internal Standardization Approaches for the Quantification of a 25 kDa Fusion Protein to Support Early Stage Drug Development by LC-MS



Request a meeting  >>

Liquid Chromatography-High Resolution Mass Spectrometry Bioanalytical Approach for the Quantification of Total Antibody-Drug Conjugate (ADC) (DAR≥0) in Rat Plasma



Request a meeting  >>

Quantification of Growth Hormone Receptor Antagonist Pegvisomant by LC-MS/MS in Rat Plasma: Method Development Considerations for PEGylated Proteins



Request a meeting  >>

We’ve added two new videos to our YouTube Channel! We hope you enjoy.

Algorithme Pharma USA

Algorithme Pharma USA video

Our Biometrics Expertise

We offer Biostatistics, Statistical Programming, CDISC Implementation and Data Migration, Clinical Data Management services, and so much more!

Algorithme Pharma USA video

Request to
Meet Us

9th WRIB

April 13-17
Miami, FL
Visit our booth #49

24th Partnerships in Clinical Trials

April 21-24
Boston, MA

Diabetes Summit

April 27-29
Boston, MA

CDISC Interchange Europe

May 5-6
Basel, Switzerland
Visit our booth #18

For more information, please contact us:
450 973-6077 | 888 267-7449 | contact@algopharm.com
©2015 All Rights Reserved, Algorithme Pharma inc. 2015